Publications by authors named "Xiao-Yu Che"

Background: Microsatellite stable (MSS) colorectal carcinomas (CRCs) exhibit poor responsiveness to immunotherapy such as immune checkpoint inhibitors (ICIs). In the realm of clinical cancer treatment, traditional Chinese medicines (TCMs) are extensively utilized for their immunomodulatory properties. Shen Qi Yi Chang (SQYC), a clinical prescription for CRC treatment, improve the life quality of CRC patients and enhance their immune function.

View Article and Find Full Text PDF

Tumor metastasis is the main cause of death in clinical patients. The proposal of the pre-metastatic microenvironment hypothesis offers a new research direction for tumor metastasis. Targeting and inhibiting the activation of the stimulator of interferon genes(STING) signals by tumor cell-derived microparticles may help reduce tumor metastasis.

View Article and Find Full Text PDF

The objective of this study was to investigate the association between pre-operative body mass index (BMI) and surgical infection in perihilar cholangiocarcinoma (pCCA) patients treated with curative resection. Consecutive pCCA patients were enrolled from four tertiary hospitals between 2008 and 2022. According to pre-operative BMI, the patients were divided into three groups: low BMI (≤18.

View Article and Find Full Text PDF

Background & Aims: Tumor-associated chronic inflammation has been determined to play a crucial role in tumor progression, angiogenesis and immunosuppression. The objective of this study was to assess the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in perihilar cholangiocarcinoma (pCCA) patients following curative resection.

Methods: Consecutive pCCA patients following curative resection at 3 Chinese hospitals between 2014 and 2018 were included.

View Article and Find Full Text PDF
Article Synopsis
  • This study looked at how blood transfusions during surgery (PBT) affect long-term survival in patients with a type of cancer called perihilar cholangiocarcinoma (pCCA).
  • They compared patients who received blood transfusions to those who didn't, separating them by different stages of the cancer.
  • Results showed that patients with early-stage pCCA who got blood transfusions had worse survival and recovery rates, while there wasn't much difference for those with later stages or all stages combined. *
View Article and Find Full Text PDF